AF12198, a Novel Low Molecular Weight Antagonist, Selectively Binds the Human Type I Interleukin (IL)-1 Receptor and Blocks in Vivo Responses to IL-1

This publication has 21 references indexed in Scilit:

• Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex
  FEBS Letters, 1995
• Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis.
  Annals of the Rheumatic Diseases, 1995
• Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis
  Arthritis & Rheumatism, 1995
• Refined Crystal Structure of the Interleukin-1 Receptor Antagonist. Presence of a Disulfide Link and a cis -Proline
  European Journal of Biochemistry, 1995
• A mutational analysis of receptor binding sites of interleukin-1β:differences in binding of human interleukin-1β muteins to human and mouse receptors
  Protein Engineering, Design and Selection, 1994
• Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica
  Cytokine, 1993
• Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
  Proceedings of the National Academy of Sciences, 1991
• Structure of interleukin 1 .alpha. at 2.7-.ANG. resolution
  Biochemistry, 1990
• Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
  International Journal of Peptide and Protein Research, 1990
• Crystallographic refinement of interleukin 1 beta at 2.0 A resolution.
  Proceedings of the National Academy of Sciences, 1989